« Personalized Genomics: The First Report of a Cancer Genome | Blog home | The "Lost Opportunity” in Phase I Oncology Trials »

November 25, 2008

Dr. Dan Von Hoff honored at Governor’s Celebration

Danvonhoff2 Our colleague Dan Von Hoff, M.D., a founder and shareholder of Medelis and the chairman of our medical advisory board, was recently named Arizona’s ‘Community Service Leader of the Year’ at the 2008 Governor’s Celebration of Innovation in Phoenix. 

A member of the NIH’s National Cancer Advisory Board, Dr. Von Hoff is a world-renowned cancer researcher who has devoted more than 35 years to two primary goals: identifying the best new anti-cancer agents to treat patients and curing pancreatic cancer. He has published more than 540 scientific papers, more than 130 book chapters, and nearly 950 scientific abstracts. He also holds a dozen patents for new anti-cancer agents and medical devices.  (Full bio here.)

The annual award honors an organization or individual who contributes to Arizona's technology industry through relentless community involvement, leadership, visibility and excellence in economic development activity.

Medelis will soon publish a new issue of “Peer Perspectives in Oncology” featuring an in-depth interview with Dan about oncology phase I trials.  He describes how Chief Medical Officers can design better phase I trials to glean meaningful efficacy data by using the patient as his or her own control. He further explains how a CMO can gather evidence showing a drug changes the natural history of a patient’s disease, demonstrating improved care and a stronger case for moving a drug into phase II. 

In our summer 2008 issue, Dan offers a detailed look at “The Complete Phase Ib,” a clinical trial structure that creates rapid accrual rates, substantial economies of scale and significant time savings for sponsors versus the traditional sequential approach.

You can download past issues and sign up to be notified of future publications here.

Subscribe

Sign up to receive new articles via email:

Delivered by FeedBurner


Subscribe with your favorite feed reader!

Add to Technorati Favorites



About us

Medelis - Oncology CRO, Oncology Drug Development - Home

Medelis is an oncology CRO that provides clinical trial planning, trial management and oncology drug development services. Learn more or contact us today.

Subscribe
 
Insider Abstracts

View, download and share our Insider Abstracts via Slideshare, a service that allows you to discover, upload, download and share presentations with colleagues and your community.

 
 
Twitter updates